Xiaoli Li is currently the Director of Antibody Development at Abcam, where they establish antibody development platforms. They have held various roles at Abcam from 2019 to 2020, including Technology Optimization Manager and Director of Antibody Engineering, Screening and Validation, specializing in rabbit monoclonal antibody development and optimization. Previously, Xiaoli completed postdoctoral research at the University of Louisville and Cincinnati Children's Hospital Medical Center, focusing on brain aging and hematology-oncology, respectively. Xiaoli pursued an extensive educational background, earning multiple degrees in clinical medicine and immunology, and is currently completing an MBA at Zhejiang University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices